Go to journal home page - Nuclear Medicine and Biology

Nuclear Medicine and Biology

$3370

Article publishing charge
for open access

16 days
Time to first decision
77 days
Review time
95 days
Submission to acceptance

Articles

Mohini Guleria, ... Tapas Das
May–June 2024
Muriel Aline Spahn, ... Frederik Cleeren
May–June 2024
Xiaohui Zhang, ... Yongjian Liu
March–April 2024View PDF
Yuli Sun, ... Jinxia Zhu
March–April 2024
Ivan E. Wang, ... Peter J.H. Scott
March–April 2024
Michael R. Dyer, ... Monica Shokeen
March–April 2024
Cassis Varlow, ... Neil Vasdev
March–April 2024View PDF
Michal Sakmár, ... Luděk Šefc
March–April 2024

More from Nuclear Medicine and Biology

Calls for papers

Practical aspects, status, and future perspectives of application of alpha-emitting radionuclides for targeted alpha therapy

Guest editors: Valery Radchenko, Cathy Cutler, Andrew Burgoyne, Amir Jalilian - Submission deadline: 1 September 2024
Targeted Alpha Therapy (TAT) holds great promise as the most efficient treatment option for late-stage metastatic cancers at the clinical level. Despite rapid progress with the clinical translation of several alpha emitters into clinical trials, …

The Future of the Radiopharmaceutical Sciences

Guest editors: Peter Scott, Suzanne Lapi - Submission deadline: 31 October 2023
A special issue of Nuclear Medicine and Biology (NMB), published by Elsevier, will be dedicated to the Future of the Radiopharmaceutical Sciences.

Special issues and article collections

The Future of the Radiopharmaceutical Sciences

Edited by Peter Scott, Suzanne Lapi
22 February 2023

Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy

Edited by Salvatore Bongarzone, Zhengxin (Jason) Cai, Fabien Caillé, Melissa Deri, Fany Pricile Ekoume, Antonio Shegani, Valery Radchenko
12 September 2022